Literature DB >> 8347477

Glutathione S-transferase expression in benign and malignant ovarian tumours.

J A Green1, L J Robertson, A H Clark.   

Abstract

Glutathione S-transferase sub-types alpha, mu and pi were assessed by immunocytochemistry in 109 biopsies of ovarian tissue, comprising malignant epithelial tissue in 86 cases and tissue of ovarian origin considered to be normal in 23. Glutathione S-transferase pi was the most prevalent, being present in all except one malignant epithelium studied and 83% of non-malignant tissue. There were no significant differences in the overall distribution of positive staining for alpha, mu and pi in the malignant and non-malignant biopsies, although the intensity of staining was greater in the malignant epithelium. Stromal staining was in general more pronounced in the malignant biopsies, and this was particularly prominent in the case of the alpha sub-type. Positive staining was seen more frequently in the less well-differentiated tumours, and a diffuse cytoplasmic pattern was the most common observation in tumours of moderate and poor differentiation. There was no significant association between survival and the presence or absence of sub-type staining of alpha and mu sub-type. For the sub-type pi, patient survival was found to correlate with the intensity of staining (on a 0-(+++) scale). Those patients showing resistance to cytotoxic chemotherapy were found to have a higher intensity of staining for GST pi than responding patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8347477      PMCID: PMC1968543          DOI: 10.1038/bjc.1993.321

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

Review 1.  Modulation of antitumor alkylating agents (AA).

Authors:  B A Teicher; E Frei
Journal:  Cancer Treat Res       Date:  1991

2.  Expression of a multidrug-resistance gene in human tumors and tissues.

Authors:  A T Fojo; K Ueda; D J Slamon; D G Poplack; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

Review 3.  Hepatocarcinogenesis: a dynamic cellular perspective.

Authors:  E Farber; D S Sarma
Journal:  Lab Invest       Date:  1987-01       Impact factor: 5.662

4.  Characterization of melphalan-glutathione adducts whose formation is catalyzed by glutathione transferases.

Authors:  D M Dulik; C Fenselau; J Hilton
Journal:  Biochem Pharmacol       Date:  1986-10-01       Impact factor: 5.858

5.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

6.  Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).

Authors:  B A Teicher; S A Holden; M J Kelley; T C Shea; C A Cucchi; A Rosowsky; W D Henner; E Frei
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

7.  Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats.

Authors:  K H Cowan; G Batist; A Tulpule; B K Sinha; C E Myers
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

8.  Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer.

Authors:  J R Sainsbury; J R Farndon; G K Needham; A J Malcolm; A L Harris
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

9.  Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.

Authors:  C G Evans; W J Bodell; K Tokuda; P Doane-Setzer; M T Smith
Journal:  Cancer Res       Date:  1987-05-15       Impact factor: 12.701

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  23 in total

Review 1.  Overcoming drug resistance in ovarian carcinoma.

Authors:  P M Fracasso
Journal:  Curr Oncol Rep       Date:  2001-01       Impact factor: 5.075

Review 2.  Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies.

Authors:  Linjuan Xu; Jing Cai; Qiang Yang; Hui Ding; Liying Wu; Tao Li; Zehua Wang
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-18       Impact factor: 4.553

3.  Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases.

Authors:  C J Henderson; A G Smith; J Ure; K Brown; E J Bacon; C R Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

4.  Impact of obesity on ovotoxicity induced by 7,12-dimethylbenz[a]anthracene in mice.

Authors:  Jackson Nteeba; Shanthi Ganesan; Aileen F Keating
Journal:  Biol Reprod       Date:  2014-03-27       Impact factor: 4.285

5.  Glutathione S-transferase expression in malignant mesothelioma and non-neoplastic mesothelium: an immunohistochemical study.

Authors:  K Segers; S Kumar-Singh; J Weyler; J Bogers; M Ramael; J Van Meerbeeck; E Van Marck
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

6.  Immunohistochemical expression of pi class glutathione S-transferase in the basal cell layer of benign prostate tissue following chronic treatment with finasteride.

Authors:  R Montironi; R Mazzucchelli; R Pomante; D Thompson; V Duval da Silva; L Vaught; P H Bartels
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

7.  Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.

Authors:  Charles Keller; Benjamin R Arenkiel; Cheryl M Coffin; Nabeel El-Bardeesy; Ronald A DePinho; Mario R Capecchi
Journal:  Genes Dev       Date:  2004-10-15       Impact factor: 11.361

8.  Expression of xenobiotic metabolizing enzymes in tumours of the urinary bladder.

Authors:  G I Murray; V E Taylor; J A McKay; R J Weaver; S W Ewen; W T Melvin; M D Burke
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

9.  Human osteosarcoma xenografts and their sensitivity to chemotherapy.

Authors:  Skjalg Bruheim; Oyvind S Bruland; Knut Breistol; Gunhild M Maelandsmo; Oystein Fodstad
Journal:  Pathol Oncol Res       Date:  2004-09-25       Impact factor: 3.201

10.  Characterization of the molecular forms of glutathione S-transferase P1 in human gastric cancer cells (Kato III) and in normal human erythrocytes.

Authors:  Perungavar N Ranganathan; Richard Whalen; Thomas D Boyer
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.